Abstract
120 patients with chronic gastritis and primary chronic gastroduodenitis were given a three-week course of etiopathogenetic treatment (antichelibacterial and immunocorrective drugs) that allowed to diminish the clinical, bacteriological and immune manifestations of the disease and achieve a complete cure in most patients. Patients with marked chelibacteriosis revealed greater refractoriness. The authors recommend prolonged courses of treatment with alternations of etiologically directed drugs.
MeSH terms
-
Adjuvants, Immunologic / therapeutic use
-
Adolescent
-
Adult
-
Anti-Bacterial Agents / therapeutic use
-
Antibodies, Bacterial / blood
-
Autoimmune Diseases / complications
-
Autoimmune Diseases / diagnosis
-
Autoimmune Diseases / drug therapy
-
Chronic Disease
-
Drug Therapy, Combination
-
Duodenitis / diagnosis
-
Duodenitis / drug therapy*
-
Duodenitis / etiology
-
Female
-
Gastritis / diagnosis
-
Gastritis / drug therapy*
-
Gastritis / etiology
-
Helicobacter Infections / complications
-
Helicobacter Infections / diagnosis
-
Helicobacter Infections / drug therapy
-
Helicobacter pylori / immunology
-
Humans
-
Male
-
Middle Aged
Substances
-
Adjuvants, Immunologic
-
Anti-Bacterial Agents
-
Antibodies, Bacterial